Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Inflammatory arthritis has the potential to cause irreversible erosive damage to cartilage and bone. This may occur very early in the course of the disease. At present it is not possible at diagnosis to identify those patients who will develop erosive damage. If this were possible, it would enable aggressive therapy to be targeted to those patients at greatest risk. There is therefore a need for sensitive markers to detect and quantify joint damage at as early a stage as possible. In this chapter we review potential biochemical markers of such damage and assess their clinical usefulness.

Original publication

DOI

10.1016/s0950-3579(05)80179-7

Type

Journal article

Journal

Baillieres clin rheumatol

Publication Date

06/1992

Volume

6

Pages

351 - 372

Keywords

Arthritis, Biomarkers, Bone Resorption, Bone and Bones, Cartilage, Articular, Collagen, Humans, Joints